抜管関連の合併症 - EXTUBE 研究 (EXTUBE) (EXTUBE)
抜管関連合併症 - 手術室と集中治療室における影響とベストプラクティスを理解するための国際観察研究 - EXTUBE 研究
EXTUBE is an international, multicentre, prospective cohort study evaluating the incidence, risk factors, and outcomes of extubation-related complications and describing clinical practices related to extubation after general anesthesia or after critical illness in the operating room (OR), out of OR anesthesia location or intensive care unit (ICU).
調査の概要
状態
状態
条件
条件
詳細な説明
Globally, over 200 million people each year require extubation. While routinely performed, extubation is a skilled and potentially high-risk procedure that should be performed only when physiologic, pharmacologic, and contextual conditions are optimal. Complications at this stage of patient care can result in decreased oxygen delivery to the brain and body, sometimes leading to serious adverse events such as cardiac arrest, brain damage, or death. Indeed, one quarter of airway complications that result in death or brain death occur at the time of extubation.
Despite the frequency of extubation and the potential for life-threatening complications, there is a lack of systematic data on the rate and circumstances under which these severe complications occur. The limited data indicate 10-30% of extubations may lead to severe complications, depending on the population and outcome definition. However, the certainty of these estimates is severely limited because they are based on studies that are small, mostly single-center, based on clinician recall, only capture a small portion of extubation complications (e.g., malpractice claims), or do not reflect current clinical practice. In addition, most lack a denominator and exclude successful extubations, making estimates of actual complication rates and risk factors impossible.
There has been no large study of extubation techniques or adherence to guidelines, so procedural factors associated with complications must be elucidated. While adherence to clinical practice guidelines has not been formally evaluated, surveys show non-adherence to some best practices and considerable variation in practice, and data from audits and medicolegal claims show that lack of adherence to best practices is frequently at the root cause of severe adverse extubation outcomes, with half of the complications deemed preventable. Therefore, data on the frequency and nature of extubation complications, patient and procedural risk factors for complications, and guideline adherence rates are needed before these preventable events can be addressed.
EXTUBE (EXtubation related complications - an international observational study To Understand the impact and BEst practices in the operating room and intensive care unit) is an international, multicenter, prospective cohort study
The primary objective of this study is to estimate the incidence of immediate complications related to extubation in adult patients after general anesthesia and/or after critical illness. The secondary objectives are to determine: 1) the incidence of mild extubation complications; 2) patient- and procedure-related risk factors for extubation complications; 3) the association between extubation complications and outcomes until hospital discharge; and 4) the rate of adherence to extubation clinical practice guidelines.
研究の種類
研究の種類
入学 (推定)
入学
連絡先と場所
研究連絡先
研究連絡先
- 名前:Matteo Parotto, MD, PhD
- 電話番号:+1 416 340 3567
- メール:matteo.parotto@uhn.ca
研究連絡先のバックアップ
- 名前:Shayan Wasim, MPH, BSc
- 電話番号:4221 +1 416 340 4800
- メール:shayan.wasim@uhn.ca
研究場所
-
-
-
Castlebar、アイルランド、F23 H529
- 完了
- Mayo University Hospital
-
Cork、アイルランド、T12 DFK4
- 完了
- Cork University Hospital
-
Dublin、アイルランド、D07 R2WY
- 完了
- Mater Misericordiae University Hospital
-
Galway、アイルランド、H91 YR71
- 完了
- Galway University Hospitals
-
Waterford、アイルランド、X91 ER8E
- まだ募集していません
- University Hospital Waterford
-
コンタクト:
- Erin Crowley, PhD, MPharm
- メール:erin.crowley@ucc.ie
-
コンタクト:
- Dulmi T Nawarathna, MBBS, MCAI, FCAI
- 電話番号:(+353) 0518482425
- メール:dulmi.nawarathna@hse.ie
-
主任研究者:
- Dulmi T Nawarathna, MBBS, MCAI, FCAI
-
副調査官:
- Sheeba Hakak, MBBS, FCARCSI, EDIC, HCM.
-
-
-
-
Arizona
-
Tucson、Arizona、アメリカ、85724-5114
- 完了
- Banner University Medical Centre
-
-
Arkansas
-
Little Rock、Arkansas、アメリカ、72205
- 完了
- University of Arkansas for Medical Sciences
-
-
Florida
-
Gainesville、Florida、アメリカ、32608
- 完了
- University of Florida
-
-
Illinois
-
Chicago、Illinois、アメリカ、60637
- 完了
- The University of Chicago
-
-
Oregon
-
Portland、Oregon、アメリカ、97239
- 完了
- Oregon Health & Science University
-
-
Texas
-
Houston、Texas、アメリカ、77030
- 完了
- The University of Texas Health Science Center
-
-
-
-
-
Bath、イギリス、BA1 3NG
- 完了
- Royal United Hospitals Bath
-
Newcastle upon Tyne、イギリス、NE7 7DN
- 完了
- Freeman Hospital
-
-
-
-
New South Wales
-
Sydney、New South Wales、オーストラリア、2065
- 完了
- Royal North Shore Hospital
-
-
Victoria
-
Melbourne、Victoria、オーストラリア、3135
- 完了
- Eastern Health - Maroondah Hospital
-
Melbourne、Victoria、オーストラリア、3156
- 完了
- Eastern Health - Angliss Hospital
-
Melbourne、Victoria、オーストラリア、3076
- 完了
- The Northern Hospital
-
Melbourne、Victoria、オーストラリア、3128
- 完了
- Eastern Health - Box Hill Hospital
-
Melbourne、Victoria、オーストラリア、3084
- 完了
- Austin Health - Austin Hospital
-
Melbourne、Victoria、オーストラリア、3079
- 完了
- Austin Health - Heidelberg Repatriation Hospital
-
-
-
-
British Columbia
-
Surrey、British Columbia、カナダ、V3V 1Z2
- 完了
- Surrey Memorial Hospital
-
-
New Brunswick
-
Moncton、New Brunswick、カナダ、E1C 4B7
- 完了
- The Moncton Hospital
-
-
Ontario
-
North York、Ontario、カナダ、M4N 3M5
- 完了
- Sunnybrook Hospital
-
Saint Catharines、Ontario、カナダ、L2S 0A9
- 完了
- Niagara Health - Marotta Family Hospital
-
Toronto、Ontario、カナダ、M5B 1W8
- 完了
- St. Michael's Hospital
-
Toronto、Ontario、カナダ、M5G 1X5
- 完了
- Mount Sinai Hospital
-
Toronto、Ontario、カナダ、M5G 2C4
- 募集
- University Health Network - Toronto General Hospital
-
コンタクト:
- Shayan Wasim, MPH, BSc
- 電話番号:4221 416-340-4800
- メール:shayan.wasim@uhn.ca
-
主任研究者:
- Matteo Parotto, MD, PhD
-
コンタクト:
- Matteo Parotto, MD, PhD
- 電話番号:416-340-3567
- メール:matteo.parotto@uhn.ca
-
副調査官:
- Alicia Grassi, MD
-
Toronto、Ontario、カナダ、M5T 2S8
- 完了
- University Health Network - Toronto Western Hospital
-
-
Quebec
-
Montreal、Quebec、カナダ、H2X 0C1
- 完了
- Centre hospitalier de l'Université de Montréal (CHUM)
-
-
-
-
-
Kuwait City、クウェート
- 完了
- Amiri Hospital
-
-
-
-
-
Piedecuesta、コロンビア
- 完了
- Hospital Internacional de Colombia
-
-
-
-
-
Singapore、シンガポール、308433
- 完了
- Tan Tock Seng Hospital
-
-
-
-
-
Auckland、ニュージーランド、1023
- 完了
- Auckland City Hospital
-
Invercargill、ニュージーランド、9812
- 完了
- Southland Hospital
-
Rotorua、ニュージーランド、3010
- 完了
- Rotorua Hospital
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
All adult patients (≥18 years old) undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU during the specified enrollment window (up to 4 weeks).
説明
Inclusion Criteria:
- Adult patients (≥18 years old)
- Undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU
- Undergoing extubation during the specified enrollment window
Exclusion Criteria:
- Patients will be excluded if the extubation is performed in the context of withdrawal of life support measures,
- Patients will be excluded if the extubation is performed for tracheostomy decannulation
For each patient who is not included, reasons for exclusion will be reported.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:COHORT
- 時間の展望:PROSPECTIVE
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
At least one of the following, occurring within 60minutes after extubation (composite outcome): i) Severe hypoxemia ii) Cardiac arrest iii) Need for airway management
時間枠:Within 60 minutes after the end of extubation
|
The primary outcome will be the occurrence of at least one of the following (composite outcome) occurring within 60 minutes after the end of extubation: i) Severe hypoxemia (oxygen saturation as measured by pulse oximetry falls below SpO2 < 80% for > 5 minutes) ii) Cardiac arrest iii) Need for airway management (reintubation, insertion of a supraglottic airway, bag-mask ventilation). |
Within 60 minutes after the end of extubation
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Difficult airway and complications related to airway management if reintubation is required
時間枠:Within 60 minutes after the end of extubation
|
Difficult airway (i.e., experienced difficulty by an experienced airway manager with any or all of laryngoscopy or tracheal intubation, supraglottic airway use, face-mask ventilation, or front-of-neck airway) and complications related to airway management (e.g., esophageal intubation) if reintubation is required |
Within 60 minutes after the end of extubation
|
|
Planned and unplanned non-invasive respiratory support
時間枠:Within 60 minutes after the end of extubation
|
Planned and unplanned non-invasive respiratory support or high flow nasal cannula |
Within 60 minutes after the end of extubation
|
|
Emergency front of neck airway
時間枠:Within 60 minutes after the end of extubation
|
Emergency front of neck airway should airway management be required after extubation |
Within 60 minutes after the end of extubation
|
|
Cardiac arrhythmia requiring chemical or electrical treatment
時間枠:Within 60 minutes after the end of extubation
|
Cardiac arrhythmia requiring chemical or electrical treatment |
Within 60 minutes after the end of extubation
|
|
Severe Hypotension
時間枠:Within 60 minutes after the end of extubation
|
Severe hypotension (systolic arterial pressure < 65 mmHg recorded at any time or systolic arterial pressure < 90 mmHg for > 30 minutes or new need/increase of vasopressor and/or fluid load > 15 mL/kg) |
Within 60 minutes after the end of extubation
|
|
Severe Hypertension
時間枠:Within 60 minutes after the end of extubation
|
Severe hypertension (systolic blood pressure ≥180 mmHg and/or diastolic blood pressure ≥120 mmHg), |
Within 60 minutes after the end of extubation
|
|
Pulmonary aspiration
時間枠:Within 60 minutes after the end of extubation
|
Aspiration of gastric contents (gastric contents inhaled into the larynx and the respiratory tract) |
Within 60 minutes after the end of extubation
|
|
Barotrauma
時間枠:Within 60 minutes after the end of extubation
|
Pneumothorax/pneumo-mediastinum |
Within 60 minutes after the end of extubation
|
|
Dental injury
時間枠:Within 60 minutes after the end of extubation
|
Dental injury (notable change to the patient's dentition attributable to extubation or to reintubation, should this be required) |
Within 60 minutes after the end of extubation
|
|
Airways injury
時間枠:Within 60 minutes after the end of extubation
|
Airways injury (e.g., vocal cord damage, arytenoid dislocation |
Within 60 minutes after the end of extubation
|
|
Mortality
時間枠:Within 7 days after extubation
|
In-hospital mortality |
Within 7 days after extubation
|
|
Re-intubation
時間枠:Within 48 hours after extubation
|
Re-intubation within 48 hours of extubation |
Within 48 hours after extubation
|
協力者と研究者
捜査官
捜査官
- 主任研究者:Matteo Parotto, MD, PhD、UHN
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
その他の研究ID番号
- 24-5811
- 4850 (その他の識別子:Clinical Trials Ontario - CTO)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。